← Back to Search

Behavioral symptom management for Sickle Cell Disease

N/A

Waitlist Available

Led By Claudia Campbell, PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 36 weeks

Awards & highlights

Study Summary

This trial is testing whether better sleep can ease pain and improve brain function in people with sickle cell disease.

Eligible Conditions

Sickle Cell Disease
Sleep Disorder
Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 36 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 36 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Change in Central Sensitization Index

Change in Clinical pain as assessed by the Brief Pain Inventory

Change in functional connectivity/cognitive task

Trial Design

2Treatment groups

Experimental Treatment

Group I: Sickle cell disease managementExperimental Treatment1 Intervention

Five sessions working one-on-one with a study interventionist, either in person or by telephone. Includes monitoring of the individual's sleep pattern, information about sickle cell disease and its management, and information about improving sleep and managing pain.

Group II: Behavioral symptom managementExperimental Treatment1 Intervention

Five sessions working one-on-one with a study interventionist, either in person or by telephone. Includes monitoring of the individual's sleep pattern, feedback and goals for improving sleep and pain management, and addressing cognitive and emotional strategies for managing sleep and pain.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Behavioral symptom management

2017

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MarylandOTHER

160 Previous Clinical Trials

302,226 Total Patients Enrolled

Johns Hopkins UniversityLead Sponsor

2,259 Previous Clinical Trials

14,820,596 Total Patients Enrolled

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,834 Previous Clinical Trials

47,310,578 Total Patients Enrolled

Media Library

Behavioral sleep interventions Clinical Trial Eligibility Overview. Trial Name: NCT03150433 — N/A

Sickle Cell Disease Research Study Groups: Behavioral symptom management, Sickle cell disease management

Sickle Cell Disease Clinical Trial 2023: Behavioral sleep interventions Highlights & Side Effects. Trial Name: NCT03150433 — N/A

Behavioral sleep interventions 2023 Treatment Timeline for Medical Study. Trial Name: NCT03150433 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 25+ accepted into this clinical experiment?

"To be eligible for the trial, potential participants must not exceed 100 years of age and need to have reached the legal age of adulthood."

Answered by AI

Are participants being accepted at this time for the trial?

"Data posted on clinicaltrials.gov affirms that this medical investigation is presently recruiting patients. The trial was initially made available on November 5th 2017 and has since been modified as recently as June 2nd 2022."

Answered by AI

How many subjects are participating in this clinical experiment?

"Indeed, the information posted on clinicaltrials.gov confirms that enrollment for this trial is ongoing. Initially posted in November of 2017, the study was last updated in June of 2022 and requires 120 participants from a single location."

Answered by AI

Could I be a qualified participant in this medical trial?

"This medical trial is recruiting up to 120 people who suffer from pain and are between the ages of 18-100. Participants must meet this criteria in order to be considered for inclusion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sleep and Pain in Sickle Cell Disease

2017. "Sleep and Pain in Sickle Cell Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03150433.